肝病营养问题再关注

doi:10.3969/j.issn.1672-5069.2014.05.001

Abstract

Duan Zhongping. Nutrition of patients with liver diseases:what is the highlight[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(5): 449-451.

[1] Plauth M,Cabre E,Riggio O,et al. ESPEN guidelines on enteral nutrition:liver disease. Clin Nutr,2006,25（2）:285-294.
[2] Plauth M,Cabre E,Campillo B,et al. ESPEN guidelines on parenteral nutrition:Hepatology. Clin Nutr,2009,28（4）:436-444.
[3] Amodio P,Bemeur C,Butterworth R,et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology,2013,58（1）:325-336.
[4] 中华医学会消化病学分会和肝病学分会. 中国肝性脑病诊治共识意见（2013年,重庆）. 中华肝脏病杂志,2013,21（9）:641-651.
[5] Tsiaousi ET,Hatzitolios AI,Trygonis SK,et al. Malnutrition in end stage liver disease:recommendations and nutritional support. J Gastroenterol Hepatol,2008,23（4）:527-533.
[6] Cregaro L,Alberino F,Amodio P,et al. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr,1996,63（4）:602-609.
[7] Campillo B,Richardet P,Scherman E,et al. Evaluation of nutritional practice in hospitalized cirrhotic patients:results of a prospective study. Nutrition,2003,19（6）:515-521.
[8] Franca A,Aangelo G,Piero A,et al. Nutrition and survival in patients with liver cirrhosis. Nutrition,2001,17（6）:445-450.
[9] Sasidharan M,Nistala S,Narendhran RT,et al. Nutritional status and prognosis in cirrhotic patients. Trop Gastroenterol,2012,33（4）:257-264.
[10] Kondrup J,Rasmussen H,Hamberg O,et al. Nutritional risk screening（NRS 2002）:a new methodbased on an analysis of controlledclinical trials. Clin Nutr,2003,22（3）:321-336.
[11] 蒋朱明,于康,朱赛楠,等. 我国东、中、西部中小医院住院患者营养不良（营养不足）、营养风险、超重和肥胖发生率及营养支持应用状况调查（中期总结）. 中国临床营养杂志,2008,16（6）:338-340.
[12] 郭会敏, 周莉, 马文晨,等. 北京地区住院肝病患者营养风险的状况. 中华肝脏病杂志,2013,21（10）:734-738.
[13] Kyle UG,Genton L,Pichard C. Low phase angle determined by bioelectrical impendance analysis is associated with malnutrition and nutritional risk at hospital admission. Clin Nutrit,2012,32（2）:294-299.
[14] Noman K,Smoliner C,Kilbert A,et al. Disease-related malnutrition but not underweight by BMI is reflected by disturbed electric tissue properties in the bioelectrical impedance vector analysis. Br J Nutrit,2008,100（3）:590-595.
[15] Barbosa-Silva MCG,Barros A J,Wang J,et al. Bioelectrical impedance analysis:population reference values for phase angle by age and sex. Am J Clin Nutrit,2005,82（1）:49-52.
[16] Oliveira C,Kubrusly M,Mota RS,et al. The phase angle and mass body cell as markers of nutritional status in hemodialysis patients. J Renal Nutrit,2010,20（5）:314-320.
[17] Hong BS,Ming K,Duan ZP,et al. Compound pollen protein nutrient increase serum albumin in cirrhotic rats. Gastroenterol Res,2010,3（6）:253-261.

Nutrition of patients with liver diseases:what is the highlight

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Ren Yufei, Chen Xiaoqing, Kong Weizong, et al.. Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro [J]. Journal of Practical Hepatology, 2019, 22(6): 804-807.
[2]	Li Yingyi, Guo Cuifen, Zhang Ruinan, et al.. Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 848-851.
[3]	Ding Wenjin, Fan Jiangao.. Management of complications associated with cholestatic liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 938-940.
[4]	. [J]. Journal of Practical Hepatology, 2019, 22(5): 624-635.
[5]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[6]	Lu Lungen. Cholestatic liver diseases：What we know and how to deal with [J]. Journal of Practical Hepatology, 2019, 22(5): 754-757.
[7]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[8]	Tang Chengwei. Chronic liver disease and thrombocytopenia：Changes in clinical management concept [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 457-458.
[9]	Yan Xisheng, Li Wei, Wang Jian, et al. Changes of serum cytokines and intestinal flora distribution in patients with alcoholic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 518-521.
[10]	Zhang Lanhua, Shao Qin, Xia Zhenjuan. Changes of serum 25-(OH) D3 and IL-17 levels are associated with progress of nonalcoholic fatty liver disease in obese children [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 522-525.
[11]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[12]	Fu Liang, Wu Dongbing, Ji Xinzun. Application of ARFI quantification in the evaluation of liver injuries in patients with non-alcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 377-380.
[13]	Wang Haifang, Yang Dawei, Jia Bei. Impact of nutrition support and medusa administration on liver function, erythrocyte and platelet parameters in patients with alcoholic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 381-384.
[14]	Zhu Guangxi，Wen Liangzhi，Chen Dongfeng. Pathogenesis of non-alcoholic fatty liver disease-related hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 453-456.
[15]	Huo Huiqin, Gong Xiaohong, Li Zhenghong. Assessment of right atrial and ventricular functions in patients with nonalcoholic fatty liver disease-induced liver cirrhosis by real-time three-dimensional echocardiography and speckle tracking imaging [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 244-247.